{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:33:01Z","timestamp":1793417581232,"version":"4.5.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Perinatally HIV-infected (PHIV) children are at risk for under-vaccination and poor vaccine response at 4 years of age. Childhood vaccine coverage and immune response were compared between PHIV and HIV-exposed uninfected (HEU) children in Latin America and the Caribbean.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      PHIV and HEU children were enrolled prospectively at 15 sites from 2002 to 2009. Full vaccination by age 4 years was defined as: 3 hepatitis B virus vaccine doses; 4 tetanus toxoid\u2013containing vaccine doses; 3 doses of\n                      <jats:italic toggle=\"yes\">Haemophilus influenzae<\/jats:italic>\n                      type b vaccine by age 12 months or \u22651 dose given after age 12 months; one measles-containing vaccine dose; one rubella-containing vaccine dose. Immunity was defined by serum antibody titer. Fisher exact test (for categorical measures) and\n                      <jats:italic toggle=\"yes\">t<\/jats:italic>\n                      test (for continuous measures) were used for comparisons.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Among 519 children seen at age 4 years, 191 had serum specimens available (137 PHIV, 54 HEU). Among those with specimens available, 29.3% initiated combination antiretroviral therapy (cART) &lt;12 months of age, 30.9% initiated at \u226512 months of age, and 39.8% had not received cART by the time they were seen at 4 years of age. At 4 years of age, 59.9% were on PI-containing cART (cART\/PI), and 20.4% were on no ART. PHIV children were less likely than HEU children to be fully vaccinated for tetanus (55.5% vs. 77.8%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.005) and measles and rubella (both 70.1% vs. 94.4%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). Among those fully vaccinated, immunity was significantly lower among PHIV than HEU for all vaccines examined: 20.9% versus 37.8% for hepatitis B virus (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.04), 72.0% versus 90.5% for tetanus (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.02), 51.4% versus 68.8% for\n                      <jats:italic toggle=\"yes\">H. influenzae<\/jats:italic>\n                      type b (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.05), 80.2% versus 100% for measles (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) and 72.9% versus 98.0% for rubella (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) vaccine, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Compared with HEU, PHIV children were significantly less likely to be immune to vaccine-preventable diseases when fully vaccinated. Strategies to increase immunity against vaccine-preventable diseases among PHIV require further study.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000001831","type":"journal-article","created":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T15:47:59Z","timestamp":1510760879000},"page":"304-309","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":18,"title":["Immunity After Childhood Vaccinations in Perinatally HIV-exposed Children With and Without HIV Infection in Latin America"],"prefix":"10.1097","volume":"37","author":[{"given":"Regina C. M.","family":"Succi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margot R.","family":"Krauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Robert","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy M.","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria I.","family":"de Moraes-Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa M.","family":"Mussi-Pinhata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noris","family":"Pavia Ruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell B.","family":"Pierre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka A.","family":"Kolevic Roca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esa\u00fa","family":"Joao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Foradori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo C.","family":"Scotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"Hazra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George K.","family":"Siberry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the NISDI Pediatric Study Group 2012","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260107","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1468-1293.2011.00982.x","article-title":"Guidance on vaccination of HIV-infected children in Europe.","volume":"13","author":"Menson","year":"2012","journal-title":"HIV Med"},{"key":"R3-20260107","article-title":"Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children.","journal-title":"Department of Health and Human Services"},{"key":"R4-20260107","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/INF.0b013e31828bbe68","article-title":"Undervaccination of perinatally HIV-infected and HIV-exposed uninfected children in Latin America and the Caribbean.","volume":"32","author":"Succi","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R5-20260107","first-page":"61","article-title":"Immunization of children at risk of infection with human immunodeficiency virus.","volume":"81","author":"Moss","year":"2003","journal-title":"Bull World Health Organ"},{"key":"R6-20260107","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1468-1293.2006.00409.x","article-title":"Prevalence of protective antibody against measles in HIV-infected children with immune recovery after highly active antiretroviral therapy.","volume":"7","author":"Aurpibul","year":"2006","journal-title":"HIV Med"},{"key":"R7-20260107","doi-asserted-by":"crossref","first-page":"e315","DOI":"10.1542\/peds.2005-2616","article-title":"Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection.","volume":"118","author":"Bekker","year":"2006","journal-title":"Pediatrics"},{"key":"R8-20260107","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/ije\/dyn239","article-title":"Cohort Profile: NICHD International Site Development Initiative (NISDI): a prospective, observational study of HIV-exposed and HIV-infected children at clinical sites in Latin American and Caribbean countries.","volume":"38","author":"Hazra","year":"2009","journal-title":"Int J Epidemiol"},{"key":"R9-20260107","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2471\/BLT.08.053819","article-title":"WHO and UNICEF estimates of national infant immunization coverage: methods and processes.","volume":"87","author":"Burton","year":"2009","journal-title":"Bull World Health Organ"},{"key":"R10-20260107","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1699-0463.1997.tb05093.x","article-title":"Improved ELISA for determination of anti-diphtheria and\/or anti-tetanus antitoxin antibodies in sera.","volume":"105","author":"Kristiansen","year":"1997","journal-title":"APMIS"},{"key":"R11-20260107","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/00034983.1999.11813407","article-title":"The influence of prematurity and low birthweight on transplacental antibody transfer in Sri Lanka.","volume":"93","author":"Wesumperuma","year":"1999","journal-title":"Ann Trop Med Parasitol"},{"key":"R12-20260107","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/infdis\/173.5.1077","article-title":"Placental transfer and maternally acquired neonatal IgG immunity in human immunodeficiency virus infection.","volume":"173","author":"de Moraes-Pinto","year":"1996","journal-title":"J Infect Dis"},{"key":"R14-20260107","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0264-410X(98)00269-2","article-title":"Seroprevalence and determinants of diphtheria, tetanus and poliomyelitis antibodies among adults in Berlin, Germany.","volume":"17","author":"Stark","year":"1999","journal-title":"Vaccine"},{"key":"R15-20260107","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/infdis\/147.6.1100","article-title":"The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b.","volume":"147","author":"K\u00e4yhty","year":"1983","journal-title":"J Infect Dis"},{"key":"R16-20260107","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/infdis\/162.5.1036","article-title":"Measles antibody: reevaluation of protective titers.","volume":"162","author":"Chen","year":"1990","journal-title":"J Infect Dis"},{"key":"R17-20260107","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1542\/peds.2008-3645","article-title":"Booster vaccinations: can immunologic memory outpace disease pathogenesis?","volume":"124","author":"Pichichero","year":"2009","journal-title":"Pediatrics"},{"key":"R18-20260107","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/QAD.0000000000000127","article-title":"Effect of HIV-1 exposure and antiretroviral treatment strategies in HIV-infected children on immunogenicity of vaccines during infancy.","volume":"28","author":"Simani","year":"2014","journal-title":"AIDS"},{"key":"R19-20260107","doi-asserted-by":"crossref","first-page":"7939","DOI":"10.1073\/pnas.0901702106","article-title":"Timing of HAART defines the integrity of memory B cells and the longevity of humoral responses in HIV-1 vertically-infected children.","volume":"106","author":"Pensieroso","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R20-20260107","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/INF.0b013e3181903ed3","article-title":"Immune responses to measles and tetanus vaccines among Kenyan human immunodeficiency virus type 1 (HIV-1)-infected children pre- and post-highly active antiretroviral therapy and revaccination.","volume":"28","author":"Farquhar","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R21-20260107","doi-asserted-by":"crossref","first-page":"e1249","DOI":"10.1016\/j.ijid.2013.07.008","article-title":"Subnormal and waning immunity to tetanus toxoid in previously vaccinated HIV-infected children and response to booster doses of the vaccine.","volume":"17","author":"Choudhury","year":"2013","journal-title":"Int J Infect Dis"},{"key":"R22-20260107","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.vaccine.2009.12.011","article-title":"Haemophilus influenzae type b disease in HIV-infected children: a review of the disease epidemiology and effectiveness of Hib conjugate vaccines.","volume":"28","author":"Mangtani","year":"2010","journal-title":"Vaccine"},{"issue":"6 Pt 1","key":"R23-20260107","doi-asserted-by":"crossref","first-page":"e641","DOI":"10.1542\/peds.111.6.e641","article-title":"Response to immunization with measles, tetanus, and Haemophilus influenzae type b vaccines in children who have human immunodeficiency virus type 1 infection and are treated with highly active antiretroviral therapy.","volume":"111","author":"Melvin","year":"2003","journal-title":"Pediatrics"},{"key":"R24-20260107","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1016\/j.vaccine.2006.01.045","article-title":"Prevalence of protective antibody against hepatitis B virus in HIV-infected children with immune recovery after highly active antiretroviral therapy.","volume":"24","author":"Siriaksorn","year":"2006","journal-title":"Vaccine"},{"key":"R25-20260107","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S1201-9712(02)90120-7","article-title":"Antibody response to hepatitis B vaccine in infants of HIV-positive mothers.","volume":"6","author":"Watanaveeradej","year":"2002","journal-title":"Int J Infect Dis"},{"key":"R26-20260107","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.vaccine.2007.12.020","article-title":"Effects of vertical HIV infection on the persistence of anti-HBs after a schedule of three doses of recombinant hepatitis B vaccine.","volume":"26","author":"Fernandes","year":"2008","journal-title":"Vaccine"},{"key":"R27-20260107","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1016\/j.vaccine.2011.03.077","article-title":"Prevalence of protective level of hepatitis B antibody 3 years after revaccination in HIV-infected children on antiretroviral therapy.","volume":"29","author":"Lao-Araya","year":"2011","journal-title":"Vaccine"},{"key":"R28-20260107","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/01.inf.0000128780.79145.5c","article-title":"Rubella immunization in human immunodeficiency virus type 1-infected children: cause for concern in vaccination strategies.","volume":"23","author":"Lima","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"R29-20260107","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/cid\/civ440","article-title":"Immunity to measles, mumps, and rubella in US children with perinatal HIV infection or perinatal HIV exposure without infection.","volume":"61","author":"Siberry","year":"2015","journal-title":"Clin Infect Dis"},{"key":"R30-20260107","first-page":"496","article-title":"[Search of antimeasles antibodies in HIV-infected children after basic immunization].","volume":"77","author":"Lindgren-Alves","year":"2001","journal-title":"J Pediatr (Rio J)"},{"key":"R31-20260107","doi-asserted-by":"crossref","first-page":"5517","DOI":"10.1016\/j.vaccine.2005.07.038","article-title":"Immunogenicity and effectiveness of Haemophilus influenzae type b conjugate vaccine in HIV infected and uninfected African children.","volume":"23","author":"Madhi","year":"2005","journal-title":"Vaccine"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006454-201804000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:45:20Z","timestamp":1786041920000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-201804000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000001831","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]}}}